Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3008460374.
Observations2
Issue DateMay 15, 2024
StatusNo Warning Letter
Establishment TypeCorporate Headquarters
Related Inspections5
Establishment Details
Firm
Aurobindo Pharma USA Inc
Location
East Windsor, New Jersey, United States
FEI Number
3008460374
Establishment Type
Corporate Headquarters
Product Type
Drugs
Issue Date
May 15, 2024
Country
United States
Inspection History, 2011 to 2026
NAI3
VAI1
OAI1
NAI means No Action Indicated. VAI means Voluntary Action Indicated. OAI means Official Action Indicated.
Talk to a Specialist